loadpatents
Patent applications and USPTO patent grants for Rodan, Gideon.The latest application filed is for "treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist".
Patent | Date |
---|---|
Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist App 20050004199 - Hartman, George ;   et al. | 2005-01-06 |
Combination of an agent that binds to the androgen receptor and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism Grant 6,376,477 - Schmidt , et al. April 23, 2 | 2002-04-23 |
Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist App 20020040039 - Hartman, George ;   et al. | 2002-04-04 |
Combination of an agent that binds to the androgen receptor and a bisphosphonic acid in the prevention and/or treatment of diseases involving calcium or phosphate metabolism App 20010003745 - Schmidt, Azriel ;   et al. | 2001-06-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.